Since the routine evaluation of ER in breast cancer focuses on the classical ER isoform of the molecular mass of 66 kDa (hence its name ERα66), aberrations in the ESR1 gene were thus far correlated with levels of classical ER isoforms but omitted other ER isoforms. Here, ESR1 is linked to breast carcinoma.